Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.340
-0.060 (-4.29%)
At close: Jul 9, 2026, 4:00 PM EDT
1.300
-0.040 (-2.99%)
After-hours: Jul 9, 2026, 4:51 PM EDT
Dermata Therapeutics Employees
Dermata Therapeutics had 9 employees as of December 31, 2025. The number of employees increased by 1 or 12.50% compared to the previous year.
Employees
9
Change (1Y)
1
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-$789,186
Market Cap
5.39M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 9 | 1 | 12.50% |
| Dec 31, 2024 | 8 | 0 | - |
| Dec 31, 2023 | 8 | 0 | - |
| Dec 31, 2022 | 8 | 0 | - |
| Dec 31, 2021 | 8 | 1 | 14.29% |
| Mar 31, 2021 | 7 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| HCW Biologics | 35 |
| Aptevo Therapeutics | 33 |
| Cardio Diagnostics Holdings | 17 |
| Soligenix | 14 |
| Genprex | 13 |
| Processa Pharmaceuticals | 12 |
| NuCana | 12 |
DRMA News
- 6 weeks ago - Dermata Therapeutics Registration statement: Registration filing - Filings
- 2 months ago - Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026 - Accesswire
- 2 months ago - Dermata Therapeutics Quarterly report: Q1 2026 - Filings
- 2 months ago - Dermata Therapeutics Earnings release: Q1 2026 - Filings
- 2 months ago - Dermata Therapeutics Proxy statement: Proxy filing - Filings
- 2 months ago - Dermata Therapeutics Proxy statement: Proxy filing - Filings
- 3 months ago - Dermata Therapeutics Proxy statement: Proxy filing - Filings
- 3 months ago - Dermata receives notice of acceptance of Australian patent application - TheFly